Paul Cos - Concepedia

Author

Paul Cos

Also Known As

Cos, P, Cos, P., Cos, Paul, Daniel Mendez-Rodriguez, Gabriel Llaurad, MarneC Vasconcelos, P Cos, P. COS, P. Cos, PAUL COS

397

Publications

15.5K

Citations

H-Index

151

Concepts

All Affiliations

University of Antwerp Ghent University KU Leuven Instituut voor Tropische Geneeskunde Instituto de Medicina Tropical “Pedro Kourí”

About

Paul Cos is an author at University of Antwerp specializing in medicine, pharmacology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	86	4.3K
2	Natural Sciences	14	15	1K
3	Engineering	10	10	518
4	Health Sciences	10	10	396
5	Education	1	1	16

Paul Cos

200

Publications

10.8K

Citations

H-Index

Page 1

	Year	Citations
Structure−Activity Relationship and Classification of Flavonoids as Inhibitors of Xanthine Oxidase and Superoxide Scavengers Paul Cos, Ying Li, M. Calomme, Journal of Natural Products	1998	1.1K
Quorum Sensing Inhibitors Increase the Susceptibility of Bacterial Biofilms to Antibiotics In Vitro and In Vivo Gilles Brackman, Paul Cos, Louis Maes, Antimicrobial Agents and Chemotherapy	2011	541
Extended Structure–Activity Relationship and Pharmacokinetic Investigation of (4-Quinolinoyl)glycyl-2-cyanopyrrolidine Inhibitors of Fibroblast Activation Protein (FAP) Koen Jansen, Leen Heirbaut, Robert Verkerk, Journal of Medicinal Chemistry Structure–activity RelationshipDrug TargetCellular PharmacologyPharmacotherapyChemical Biology	2014	264
Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold Koen Jansen, Leen Heirbaut, Jonathan D. Cheng, ACS Medicinal Chemistry Letters Bioorganic ChemistrySelective InhibitorsChemical BiologyPharmaceutical ChemistryMedicinal Chemistry	2013	246
Non‐Thermal Plasma as a Unique Delivery System of Short‐Lived Reactive Oxygen and Nitrogen Species for Immunogenic Cell Death in Melanoma Cells Abraham Lin, Yury Gorbanev, Joey De Backer, Advanced Science	2019	235
In Vitro Susceptibilities of <i>Leishmania donovani</i> Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences M Vermeersch, Raquel Inocêncio da Luz, K. Toté, Antimicrobial Agents and Chemotherapy Sodium StibogluconateBiochemistryDifferential Susceptibility DeterminesMedicineAntiparasitic Agent	2009	227
Screening of some Tanzanian medicinal plants from Bunda district for antibacterial, antifungal and antiviral activities Sheila Maregesi, Luc Pieters, Olipa Ngassapa, Journal of Ethnopharmacology Medicinal ChemistryAntifungal AgentAntifungal AgentsHerbal MedicinePharmacology	2008	187
In Vitro Antioxidant Profile of Phenolic Acid Derivatives Paul Cos, Padinchare Rajan, Irina Vedernikova, Free Radical Research Vitro Antioxidant ProfileBiochemistryMedicineCaffeic Acid AnilidesWine Perception	2002	162
PLGA nanoparticles and nanosuspensions with amphotericin B: Potent in vitro and in vivo alternatives to Fungizone and AmBisome H. Van de Ven, Caroline Paulussen, Pim‐Bart Feijens, Journal of Controlled Release NanomedicineAntifungal AgentEngineeringVivo AlternativesMedicine	2012	156
Inhibitory Effect of Biocides on the Viable Masses and Matrices of <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i> Biofilms K. Toté, Tessa Horemans, Dirk Vanden Berghe, Applied and Environmental Microbiology	2010	155

Page 1